Floatz logo

Ginaton

Nervous System Diseases

Dongzhimen Hospital, BeijingN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

35 Active assets in the Nervous System Diseases cohort.

Asset / SponsorPhaseRating
Ginkgolide
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4BB
Guanfacine
Maimonides Medical Center
Phase 4BB
Guanfacine
Maimonides Medical Center
Phase 4BB
Opc-34712
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3BB
D-thioctic acid
Ain Shams University
Phase 4BB

View all 50 →

Same molecule, other indications

Ginaton is also rated in:

cerebral infarctionDormant
D
Indicative ·
30 / 100
View asset →
brain ischemiaDormant
D
Indicative ·
30 / 100
View asset →
brain infarctionDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →